Enrico Santus
Enrico Santus is a Data Science Leader at Bayer. After obtaining his PhD at the Chinese and Bilingual Studies department of The Hong Kong Polytechnic University, he worked in several academic institutions, including CSAIL (MIT), in the group of Regina Barzilay. Enrico has published over 50 papers on topics related to the application of Artificial Intelligence to Precision Medicine, Epidemiology, Oncology and Cardiology. His work includes research on natural language processing approaches for the automatic fake news detection and sentiment analysis.
Enrico collaborated to the creation of The Prayer (artist: Diemut Strebe), a mouth-shaped robot which produces original prayers and that was exposed at the Centre Pompidou of Paris. He is the first author of a fact sheet about Artificial Intelligence for the American Congress (https://www.belfercenter.org/publication/technology-factsheet-artificial-intelligence) and, in 2019, he was invited speaker at the Record Management Office of the White House.
Claim to fame: From art to science, from politics to healthcare, Enrico has shown how natural language processing and machine learning will be impacting our lives in the years to come.
Daniel Franke
Daniel Franke is a Senior Associate in the Technology Investment team at M Ventures, the corporate venture capital arm of Merck KGaA, Darmstadt, Germany. Daniel obtained his Bachelor’s and Master’s in Chemistry at RWTH Aachen University before moving on to the Massachusetts Institute of Technology for his Ph.D. studies. At MIT, Daniel developed functional materials for display technologies and advanced biomedical imaging applications, leading to a pending patent application for a novel biomedical imaging platform on basis of shortwave infrared light. At M Ventures, Daniel is primarily focused on investment in the semiconductor and advanced computing space.
Aleksandra Kovacevic
Aleksandra is leading privacy-by-design efforts at HERE Technologies. After a decade R&D and product management in the area of Big Data analytics, fascinated by the conflicting needs to preserve the data value while protecting privacy, she started working on anonymization technologies for location data and expanded to privacy- and ethics-by-design enabling product differentiating capabilities.
Anjana Rao
Tanaz Sharifnia
Tanaz Sharifnia is a research scientist and investigator in the Chemical Biology and Therapeutics Science Program at the Broad Institute of Harvard and MIT. Her research interests include applying systematic functional genomic and small-molecule-based approaches to discover and target cancer vulnerabilities. Working in close partnership with other scientists, clinicians, a medical research foundation, and patients, she seeks to translate basic research insights into new therapies for patients with intractable cancers. Dr. Sharifnia received her Ph.D. in the field of cancer genomics from Harvard University.
